Bcl-x
Catalog Number:OM638971
Product Profile
Product Name
Bcl-x
Antibody Type
Primary Antibodies
Product description
Bcl-x, a member of the Bcl-2 protein family, inhibits cell death, or apoptosis (1). Bcl-x is expressed as two isomeric forms, Bcl-xL and Bcl-xS, and is typically present in the cytosol in association with the mitochondrial membrane. Bcl-xL forms heterodimers with various proteins, including Bax, Bak and Bcl-2 (2). It has been found that heterodimerization with Bax does not seem to be required for anti-apoptotic activity (3). Since Bcl-xL can form an ion channel in synthetic lipid membranes, there is a strong possibility that this property plays a role in heterodimerization-independent cell survival (4). The Bcl-X(S) isoform promotes apoptosis.
Immunogen
peptide
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WB ICC IHC FC IP
WB :1:500-1,000ICC :1:100IHC :1:50-100IP :1:10FC :1:50
Species Reactivity
Human Mouse Rat
Concentration
1 mg/mL.
Target Information
Alternative Names
Apoptosis regulator Bcl X antibody
Bcl 2 like 1 antibody
Bcl 2 like 1 protein antibody
Bcl xL antibody
BCL XL/S antibody
Bcl xS antibody
Bcl2 like1 antibody
BCL2-related gene antibody
BCL2-related protein long isoform included BCLXL included antibody
BCL2-related protein short isoform included BCLXS included antibody
BCL2L antibody
BCL2L1 antibody
Bclx antibody
DKFZp781P2092 antibody
MGC113803 antibody
MGC99998 antibody
Molecular Weight(MW)
26 (Bcl-xL) / 19 (Bcl-xS)
Cellular Localization
Cytoplasm, Nucleus membrane, Cytoplasmic vesicle Mitochondrion matrix, Mitochondrion outer/ inner membrane
Database Links
Application
Application
Fig1: Western blot analysis of K562 cell lysate using anti-Bcl-x.
Application
Fig2: Immunohistochemical analysis of human paraffin-embedded prostate carcinoma tissue using anti-Bcl-x.
Positive Control
K562, human paraffin-embedded prostate carcinoma tissue.
Application Notes
WB :1:500-1,000ICC :1:100IHC :1:50-100IP :1:10FC :1:50
Additional Information
Form
Liquid
Storage Instructions
Store at -20 ℃. Stable for 12 months from date of receipt
Storage Buffer
1*TBS (pH7.4), 0.5%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.
Catalog Number:
OM638971
Price:
$ 336.00
Discount Price
Size:
100 μl
Store:
Out of stock
Lead time:
4~6 Week
Quantity:
-
+
Shipping to (Please select)
Afghanistan
Albania
Algeria
Andorra
Angola
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Brazil
Brunei
Bulgaria
Cambodia
Cameroon
Canada
Cape Verde
Central African Republic
Chad
Chile
China
Comoros
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Ecuador
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia, The
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, South
Kuwait
Latvia
Lebanon
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Morocco
Mozambique
Myanmar
Nepa
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saint Kitts and Nevis
Samoa
Sao Tome and Principe
Senegal
Seychelles
Singapore
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
The Republic of Colombia
Togo
Tonga
Tunisia
Turkey
Tuvalu
Uganda
Ukraine
United Kingdom
United States
Uruguay
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Contact our distributors
Afghanistan
Albania
Algeria
Andorra
Angola
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Brazil
Brunei
Bulgaria
Cambodia
Cameroon
Canada
Cape Verde
Central African Republic
Chad
Chile
China
Comoros
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Ecuador
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia, The
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, South
Kuwait
Latvia
Lebanon
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Morocco
Mozambique
Myanmar
Nepa
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saint Kitts and Nevis
Samoa
Sao Tome and Principe
Senegal
Seychelles
Singapore
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
The Republic of Colombia
Togo
Tonga
Tunisia
Turkey
Tuvalu
Uganda
Ukraine
United Kingdom
United States
Uruguay
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe